Subscribe to RSS
Please copy the URL and add it into your RSS Feed Reader.
https://www.thieme-connect.de/rss/thieme/en/10.1055-s-00000083.xml
Synlett 2015; 26(14): 1981-1984
DOI: 10.1055/s-0034-1380427
DOI: 10.1055/s-0034-1380427
letter
Continuous-Flow Kinetic Resolution of (±)-cis-1-Amino-2-indanol by Lipase-Catalyzed N-Acetylation
Further Information
Publication History
Received: 21 April 2015
Accepted after revision: 15 May 2015
Publication Date:
29 July 2015 (online)
Abstract
Selective N-acetylation of (1S,2R)-1-amino-2-indanol by immobilized lipase B from Candida antarctica showed high enantiomeric excess when ethyl acetate was used as the acyl donor in a THF solution. Combining this process with continuous-flow system, we could obtain enantiomerically pure N-acetyl-aminoindanol at a flow rate of 0.1 mL/min (residence time of 64 min). It has been demonstrated to be more efficient compared to the flask mode.
Key words
(±)-cis-1-amino-2-indanol - Novozyme 435® - continuous-flow system - kinetic resolution - selective N-acetylationSupporting Information
- Supporting information for this article is available online at http://dx.doi.org/10.1055/s-0034-1380427.
- Supporting Information
-
References and Notes
- 1 Kagan H, Fiaud J. Top. Stereochem. 1988; 18: 249
- 2a Ferreira EM, Stoltz BM. J. Am. Chem. Soc. 2001; 123: 7725
- 2b Ruble JC, Latham HA, Fu GC. J. Am. Chem. Soc. 1997; 119: 1492
- 2c Miller SJ, Copeland GT, Papaioannou N, Horstmann TE, Ruel EM. J. Am. Chem. Soc. 1998; 120: 1629
- 3a Nestl BM, Nebel BA, Hauer B. Curr. Opin. Chem. Biol. 2011; 15: 187
- 3b Jaeger K.-E, Eggert T. Curr. Opin. Chem. Biol. 2002; 13: 390
- 4 Hessel V, Hardt S, Löwe H, Müller A, Kolb G. Chemical Micro Process Engineering . Vol. 1 and 2. Wiley-VCH; Weinheim: 2005
- 5a Itabaiana IJr, Gonçalves KM, Zoumpanioti M, Leal IC, de Miranda LS, Xenakis A, de Souza RO. Org. Process Res. Dev. 2014; 18: 1372
- 5b Junior II, Flores MC, Sutili FK, Leite SG, de Miranda LS, Leal IC, de Souza RO. Org. Process Res. Dev. 2011; 16: 1098
- 5c Porcar R, Sans V, Ríos-Lombardía N, Gotor-Fernández V, Gotor V, Burguete MI, García-Verdugo E, Luis SV. ACS Catal. 2012; 2: 1976
- 5d Sahin S, Mäki-Arvela P, Kangas M, Eränen K, Wärnnå J, Salmi T, Murzin DY. Kinet. Catal. 2012; 53: 673
- 5e Strompen S, Weiß M, Gröger H, Hilterhaus L, Liese A. Adv. Synth. Catal. 2013; 355: 2391
- 5f Wiles C, Hammond MJ, Watts P. Beilstein J. Org. Chem. 2009; 5: 27
- 5g Žnidaršič-Plazl P, Plazl I. Process Biochem. 2009; 44: 1115
- 6 Tomin A, Hornyánszky G, Kupai K, Dorkó Z, Ürge L, Darvas F, Poppe L. Process Biochem. (Oxford, U.K.) 2010; 45: 859
- 7 de Miranda AS, Miranda LS, de Souza RO. Org. Biomol. Chem. 2013; 11: 3332
- 8a Dorsey BD, Levin RB, McDaniel SL, Vacca JP, Guare JP, Darke PL, Zugay JA, Emini EA, Schleif WA. J. Med. Chem. 1994; 37: 3443
- 8b Vieth M, Cummins DJ. J. Med. Chem. 2000; 43: 3020
- 8c Kheffache D, Guemmour H, Dekhira A, Benaboura A, Ouamerali O. J. Mol. Model. 2013; 19: 4837
- 9a Hong Y, Gao Y, Nie X, Zepp CM. Tetrahedron Lett. 1994; 35: 6631
- 9b Kobayashi T, Tanaka K, Miwa J, Katsumura S. Tetrahedron: Asymmetry 2004; 15: 185
- 9c Palmer M, Walsgrove T, Wills M. J. Org. Chem. 1997; 62: 5226
- 9d Andreana PR, Liu CC, Schreiber SL. Org. Lett. 2004; 6: 4231
- 10 Boros Z, Falus P, Márkus M, Weiser D, Oláh M, Hornyánszky G, Nagy J, Poppe L. J. Mol. Catal. B: Enzym. 2013; 85: 119
- 11 Frings K, Koch M, Hartmeier W. Enzyme Microb. Technol. 1999; 25: 303
- 12 Gotor-Fernández V, Busto E, Gotor V. Adv. Synth. Catal. 2006; 348: 797
- 13 Chen CS, Fujimoto Y, Girdaukas G, Sih CJ. J. Am. Chem. Soc. 1982; 104: 7294
- 14 Flask Reaction – General Procedure To a separate small vials containing 0.2 M solutions of (±)-cis-1-amino-2-indanol (298 mg, 2.0 mmol) in THF–EtOAc (0.5 mL, 50 equiv), Novozyme 435® (20 mg) was added to each vial in one portion, and the turbid solutions were shaken (125 rpm) at 30 °C. After 6 h, 12 h, 24 h, and 48 h, the enzyme was filtered off from the samples. For HPLC analysis, samples were diluted with EtOH (0.5 mL).
- 15 (1S,2R)-1-Acetamido-2-indanol (2) White solid; [α]D 20 +11.7 (c 0.25, CHCl3). IR (neat): 3444, 3299, 1539 cm–1. 1H NMR (400 MHz, CDCl3): δ = 7.22 (s, 4 H), 6.23 (d, J = 7.2 Hz, NH), 5.32 (dd, J = 8.2, 5.1 Hz, 1 H), 4.57 (td, J = 5.1, 2.3 Hz, 1 H), 3.13 (dd, J =16.5, 5.3 Hz, 1 H), 291 (dd, J = 16.5, 2.1 Hz, 1 H), 2.57 (br s, 1 H), 2.07 (s, 3 H). 13C NMR (100 MHz, CDCl3): δ = 170.9, 140.6, 139.9, 128.2, 127.2, 125.3, 124.5, 73.5, 57.6, 39.6, 23.3. ESI-HRMS: m/z calcd for C11H14NO2 +: 192.1019; found: 192.1016 [M + H]+.
- 16 Continuous-Flow Reaction, General Procedure Novozyme 435® (2.0 g) was packed into a glass column with an aluminum heating jacket for maintaining temperature at 30 °C. The column was fully washed with THF and then fed with a solution of (±)-cis-1-amino-2-indanol (0.1 M) in EtOAc and THF (1:1). At various flow rates (2.0, 1.0, 0.5, 0.25, and 0.1 mL/min), 1 mL of samples were collected. For HPLC analysis, samples were diluted with EtOH (0.5 mL).